Search research articles
Contact Us
Filters
Showing results (221-230 of 635) with videos related to
Page
of 64
Sort By:
Journal of Asthma and Allergy
|
April 22, 2014
Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients
David Price, Vicky Thomas, Julie von Ziegenweidt, et al.
Allergy and Asthma Proceedings
|
August 4, 2012
MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety
Eli O Meltzer, Craig LaForce, Paul Ratner, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
April 29, 2008
EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 - a summary
Mike Thomas, Barbara P Yawn, David Price, et al.
European Radiology
|
December 3, 2024
The impact of 3D real-IR delayed post gadolinium MRI parameterisation on the diagnostic performance and optimal descriptor selection in Ménière's disease
Steve Connor, Irumee Pai, Philip Touska, et al.
NPJ Primary Care Respiratory Medicine
|
December 7, 2017
Author Correction: The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β<sub>2</sub>-agonists in the United Kingdom: a cross-sectional analysis
Ian D Pavord, Nicola Mathieson, Anna Scowcroft, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
December 19, 2013
Impact of night-time symptoms in COPD: a real-world study in five European countries
David Price, Mark Small, Gary Milligan, et al.
Canadian Family Physician Medecin De Famille Canadien
|
June 4, 2016
Greener medical homes: Environmental responsibility in family medicine
Elaine Blau, Farhan M Asrar, Neil Arya, et al.
Canadian Family Physician Medecin De Famille Canadien
|
June 4, 2016
[Des centres de médecine plus écologiques: Responsabilité environnementale en médecine familiale]
Elaine Blau, Farhan M Asrar, Neil Arya, et al.
NPJ Primary Care Respiratory Medicine
|
March 9, 2017
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β<sub>2</sub>-agonists in the United Kingdom: a cross-sectional analysis
Ian D Pavord, Nicola Mathieson, Anna Scowcroft, et al.
NPJ Primary Care Respiratory Medicine
|
June 13, 2015
Initial step-up treatment changes in asthmatic children already prescribed inhaled corticosteroids: a historical cohort study
Steve W Turner, Kathryn Richardson, Annie Burden, et al.
Page
of 64
Search research articles
Search
Showing results (221-230 of 635) with videos related to
Sort By:
Page
of 64
Journal of Asthma and Allergy
|
April 22, 2014
Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients
David Price, Vicky Thomas, Julie von Ziegenweidt, et al.
Allergy and Asthma Proceedings
|
August 4, 2012
MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety
Eli O Meltzer, Craig LaForce, Paul Ratner, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
April 29, 2008
EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 - a summary
Mike Thomas, Barbara P Yawn, David Price, et al.
European Radiology
|
December 3, 2024
The impact of 3D real-IR delayed post gadolinium MRI parameterisation on the diagnostic performance and optimal descriptor selection in Ménière's disease
Steve Connor, Irumee Pai, Philip Touska, et al.
NPJ Primary Care Respiratory Medicine
|
December 7, 2017
Author Correction: The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β<sub>2</sub>-agonists in the United Kingdom: a cross-sectional analysis
Ian D Pavord, Nicola Mathieson, Anna Scowcroft, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
December 19, 2013
Impact of night-time symptoms in COPD: a real-world study in five European countries
David Price, Mark Small, Gary Milligan, et al.
Canadian Family Physician Medecin De Famille Canadien
|
June 4, 2016
Greener medical homes: Environmental responsibility in family medicine
Elaine Blau, Farhan M Asrar, Neil Arya, et al.
Canadian Family Physician Medecin De Famille Canadien
|
June 4, 2016
[Des centres de médecine plus écologiques: Responsabilité environnementale en médecine familiale]
Elaine Blau, Farhan M Asrar, Neil Arya, et al.
NPJ Primary Care Respiratory Medicine
|
March 9, 2017
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β<sub>2</sub>-agonists in the United Kingdom: a cross-sectional analysis
Ian D Pavord, Nicola Mathieson, Anna Scowcroft, et al.
NPJ Primary Care Respiratory Medicine
|
June 13, 2015
Initial step-up treatment changes in asthmatic children already prescribed inhaled corticosteroids: a historical cohort study
Steve W Turner, Kathryn Richardson, Annie Burden, et al.
Page
of 64